Martin Bryden and Dr. Nial Wheate join me from Canngea. We had a discussion about their business and what they are currently working on in the cannabis industry. We spoke on topics like the current state of the medical, nutraceutical, and recreational industries. Dr Nial Wheate broke down clinical trials and the bioavailability of cannabis. 

To let you know Canngea is an Australian company that operates as a B2B Contract Manufacturing Organisation. They focus on Eu-GMP standards (Good Management Practices) and SOP’s (Standard Operating Procedures). Canngea can deliver consistent high-quality products at competitive rates. 

They were established in Australia in September 2017. Canngea offers services to other companies in the medicinal cannabis industry to supply white label and private label solutions to produce products for wholesale in the domestic and international markets.

Today, Cannatrek is a leading Australian medicinal cannabis company specialising in cultivation, manufacturing, and digital healthcare distribution across Australia. They have a full suite of medicinal cannabis licenses which provide them with complete control of the entire product lifecycle, from growth and processing through to distribution and sales. Featuring a digital healthcare platform that connects doctors, patients, and pharmacists with their products, Cannatrek streamlines the entire medicinal cannabis process for all.

After 9 years of intensive design, development and commercial testing, VCT are proud to offer this leading development to the cannabis growing industry.

Every climate cell in a Cannabis Series system is automatically monitored. Managed to maintain pre-set temperature, humidity, CO², watering and LED lighting levels to achieve optimum plant growth for the crop varieties planted. Any variation from presets or system function error is automatically identified, logged and reported by SMS text message or email.

HH Global Alliance LLC is grounded in practical commercial theory and research mastering horticulture, production, and logistics of international cannabis commerce. We strive to standardize the rules of engagement and reverse engineer the supply chain. Shifting legal frameworks, inconsistent operating procedures, sub-par product development, and poor market execution remain a constant problem in the industry. As new regulations are introduced and rapidly evolve, a profitable cannabis industry growth strategy requires tactical planning and precision.

An Australian Medical Cannabis Industry Association serving the interests of a variety of organisations and individuals across the Australian medicinal cannabis industry.

The Medicinal Cannabis Industry Australia (MCIA) and Medical Cannabis Council (MCC) on a podcast about current issues facing the Australian Cannabis industry. Rosemary Richards, Peter Crock, Carol Ireland are interviewed by Joshua Savage and the Australia Cannabis Marketplace (ACM).

Sigma Analytical Granted GMP Certification by the Australian Therapeutic Goods Administration Toronto-based lab expands support for Canadian cannabis products to be exported to Australia

CBD Pharma was born in 2017, with a vision to enable access to high quality and affordable medicinal cannabis products for every Australian who would benefit from its therapeutic use. They provide customers with a range of medicinal cannabis products and services.